Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-12 · accession 0001367644-25-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-04 | 2025-02-12 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | D - Sale to Iss | $0.00 | -30.0K | 138.5K | -18% | $0 |
| 2025-03-04 | 2025-03-01 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $7.48 | -313 | 114.2K | -0.3% | -$2,341 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-12 | D | D | 24,078 | $0.00 | 114,469 | D | — | — | (F2) Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. On February 12, 2025, the final certification date, the Compensation Committee certified the achievement of the 2022-2024 PSUs at a payout factor of 0.00% of target resulting in the actual award of 0 shares of common stock, which is below the 24,078 shares previously reported on December 9, 2022. |
| 2 | Common | Common Stock | 2025-02-12 | D | D | 5,913 | $0.00 | 138,547 | D | — | — | (F1) Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. On February 12, 2025, the final certification date, the Compensation Committee certified the achievement of the 2022-2024 PSUs at a payout factor of 0.00% of target resulting in the actual award of 0 shares of common stock, which is below the 5,913 shares previously reported on April 8, 2022. |
| 3 | Common | Common Stock | 2025-03-01 | F | D | 313 | $7.48 | 114,156 | D | — | — | (F3) Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units |